Filtros : "Theravance" Limpar

Filtros



Refine with date range


  • Source: Movement disorders. Unidade: FM

    Subjects: ASSISTÊNCIA À SAÚDE, DOENÇA DE PARKINSON, QUALIDADE DE VIDA

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      RAJAN, Roopa et al. Integrated Care in Parkinson's Disease: a Systematic Review andMeta-Analysis. Movement disorders, v. 35, n. 9, p. 1509-1531, 2020Tradução . . Disponível em: https://doi.org/10.1002/mds.28097. Acesso em: 05 jan. 2026.
    • APA

      Rajan, R., Brennan, L., Bloem, B. R., Dahodwala, N., Gardner, J., Goldman, J. G., et al. (2020). Integrated Care in Parkinson's Disease: a Systematic Review andMeta-Analysis. Movement disorders, 35( 9), 1509-1531. doi:10.1002/mds.28097
    • NLM

      Rajan R, Brennan L, Bloem BR, Dahodwala N, Gardner J, Goldman JG, Grimes DA, Iansek R, Kovacs N, Piemonte MEP. Integrated Care in Parkinson's Disease: a Systematic Review andMeta-Analysis [Internet]. Movement disorders. 2020 ; 35( 9): 1509-1531.[citado 2026 jan. 05 ] Available from: https://doi.org/10.1002/mds.28097
    • Vancouver

      Rajan R, Brennan L, Bloem BR, Dahodwala N, Gardner J, Goldman JG, Grimes DA, Iansek R, Kovacs N, Piemonte MEP. Integrated Care in Parkinson's Disease: a Systematic Review andMeta-Analysis [Internet]. Movement disorders. 2020 ; 35( 9): 1509-1531.[citado 2026 jan. 05 ] Available from: https://doi.org/10.1002/mds.28097
  • Source: Journal of the american college of cardiology. Unidade: FM

    Subjects: ANTICOAGULANTES, FIBRILAÇÃO ATRIAL, ACIDENTE VASCULAR CEREBRAL, AMÉRICA LATINA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CORBALAN, Ramon e NICOLAU, Jose Carlos. Edoxaban versus warfarin in Latin American Patients with atrial fibrillation the ENGAGE AF-TIMI 48 trial. Journal of the american college of cardiology, v. 72, n. 13, p. 1466-1475, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.jacc.2018.07.037. Acesso em: 05 jan. 2026.
    • APA

      Corbalan, R., & Nicolau, J. C. (2018). Edoxaban versus warfarin in Latin American Patients with atrial fibrillation the ENGAGE AF-TIMI 48 trial. Journal of the american college of cardiology, 72( 13), 1466-1475. doi:10.1016/j.jacc.2018.07.037
    • NLM

      Corbalan R, Nicolau JC. Edoxaban versus warfarin in Latin American Patients with atrial fibrillation the ENGAGE AF-TIMI 48 trial [Internet]. Journal of the american college of cardiology. 2018 ; 72( 13): 1466-1475.[citado 2026 jan. 05 ] Available from: https://doi.org/10.1016/j.jacc.2018.07.037
    • Vancouver

      Corbalan R, Nicolau JC. Edoxaban versus warfarin in Latin American Patients with atrial fibrillation the ENGAGE AF-TIMI 48 trial [Internet]. Journal of the american college of cardiology. 2018 ; 72( 13): 1466-1475.[citado 2026 jan. 05 ] Available from: https://doi.org/10.1016/j.jacc.2018.07.037

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2026